Samsara BioCapital

Samsara BioCapital as of Sept. 30, 2020

Portfolio Holdings for Samsara BioCapital

Samsara BioCapital holds 36 positions in its portfolio as reported in the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Forma Therapeutics Hldgs 20.7 $74M 1.5M 49.84
Nkarta (NKTX) 17.1 $61M 2.0M 30.06
Iveric Bio 5.3 $19M 3.4M 5.64
Springworks Therapeutics (SWTX) 5.3 $19M 398k 47.67
Curevac N V (CVAC) 4.8 $17M 370k 46.55
Sutro Biopharma (STRO) 4.7 $17M 1.7M 10.05
Intercept Pharmaceuticals In 4.7 $17M 404k 41.46
Allakos (ALLK) 4.4 $16M 192k 81.45
Unum Therapeutics Ord 3.7 $13M 5.7M 2.34
Syros Pharmaceuticals 3.2 $12M 1.4M 8.24
Odonate Therapeutics Ord 3.1 $11M 815k 13.43
Atreca Inc Cl A (BCEL) 2.4 $8.6M 618k 13.97
Verona Pharma Spons Ads (VRNA) 1.9 $6.9M 1.1M 6.24
Aeglea Biotherapeutics 1.7 $6.3M 884k 7.09
Equillium (EQ) 1.7 $6.2M 1.1M 5.77
Aclaris Therapeutics (ACRS) 1.5 $5.5M 2.2M 2.57
Bctg Acquisition Corp 1.4 $5.2M 500k 10.36
Rhythm Pharmaceuticals (RYTM) 1.4 $5.1M 235k 21.67
Panacea Acquisition Corp. Unit 1.3 $4.8M 400k 12.00
Alpine Immune Sciences 1.2 $4.3M 494k 8.79
Kala Pharmaceuticals 0.9 $3.4M 451k 7.50
Albireo Pharma 0.9 $3.3M 100k 33.37
Geron Corporation (GERN) 0.7 $2.7M 1.5M 1.74
Allovir (ALVR) 0.7 $2.5M 91k 27.50
Novavax (NVAX) 0.7 $2.3M 22k 108.36
Fulcrum Therapeutics (FULC) 0.7 $2.3M 294k 7.93
Rocket Pharmaceuticals (RCKT) 0.6 $2.3M 100k 22.86
Aimmune Therapeutics 0.6 $2.0M 58k 34.45
Catabasis Pharmaceuticals Ord 0.5 $1.9M 300k 6.19
Spero Therapeutics (SPRO) 0.5 $1.8M 160k 11.16
Urovant Sciences 0.4 $1.5M 158k 9.34
Hookipa Pharma Inc equity 0.3 $1.1M 117k 9.47
Kalvista Pharmaceuticals (KALV) 0.3 $1.1M 84k 12.59
BioNTech SE Spons Ads (BNTX) 0.2 $879k 13k 69.21
Ngm Biopharmaceuticals 0.2 $580k 37k 15.91
Amarin Corp Spons Adr New (AMRN) 0.0 $105k 25k 4.20